The DOI matches its Crossref record; 395 of the 395 references it cites were found in a registry or an index.
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–395 of 395
Fakhfouri, G., Ahmadiani, A., Rahimian, R., Grolla, A. A., Moradi, F., & Haeri, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.013 · Cited by 128
Cani, P. D. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03866.x · Cited by 128
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
Matias, I., Chen, J., PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H. ‐., Shi, L., Protzman, C. E., Li, C., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061705 · Cited by 128
Bradshaw, H. B., Rimmerman, N., Hu, S. S., Benton, V. M., Stuart, J. M., Masuda, K. R., Cravatt, B. F., O’Dell, D. K., & Walker, J. M. (2009) · BMC Biochemistry · doi:10.1186/1471-2091-10-14 · Cited by 128
Ghosh, S., Wise, L. E., Chen, Y., Gujjar, R., Mahadevan, A., Cravatt, B. F., & Lichtman, A. H. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.06.020 · Cited by 127
Staiano, R. I., Loffredo, S., Borriello, F., Iannotti, F. A., Piscitelli, F., Orlando, P., Secondo, A., Granata, F., Lepore, M. T., Fiorelli, A., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi1214-584r · Cited by 126
Self-citationAnandamide and noladin ether prevent neurotoxicity of the human amyloid-β peptide
Milton, N. G. N. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00936-9 · Cited by 125
Finding of endocannabinoids in human eye tissues: Implications for glaucoma
Chen, J., Matias, I., Dinh, T., Lu, T., Venezia, S., Nieves, A. L., Woodward, D. F., & Marzo, V. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.095 · Cited by 124
Dowie, M. J., Bradshaw, H. B., Howard, M. L., Nicholson, L. F. B., Faull, R. L. M., Hannan, A. J., & Glass, M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.014 · Cited by 123
Raboune, S., Stuart, J. M., Leishman, E., Takacs, S. M., Rhodes, B. P., Basnet, A., Jameyfield, E., McHugh, D., Widlanski, T. S., & Bradshaw, H. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00195 · Cited by 123
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution
Skaper, S. D., Facci, L., Barbierato, M., Zusso, M., Bruschetta, G., Impellizzeri, D., Cuzzocrea, S., & Giusti, P. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9253-8 · Cited by 122
Mailleux, P., & Vanderhaeghen, J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09807.x · Cited by 122
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
Mazzola, C., Micale, V., & Drago, F. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.026 · Cited by 122
Bhaskaran, M. D., & Smith, B. N. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.01.021 · Cited by 122
Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse
da Cruz, J. F. O., Robin, L. M., Drago, F., Marsicano, G., & Metna‐Laurent, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.002 · Cited by 121
González, S. R., Scorticati, C., Garcı́a-Arencibia, M., de Miguel, R., Ramos, J. A., & Fernández‐Ruíz, J. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.014 · Cited by 118
PETROCELLIS, L. D., Chu, C. J., Moriello, A. S., Kellner, J. C., Walker, J. M., & Marzo, V. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705924 · Cited by 117
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination
Wu, C., Chen, H., Sun, H., Zhu, J., Jew, C. P., Wager‐Miller, J., Straiker, A. J., Spencer, C. M., Bradshaw, H. B., Mackie, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060314 · Cited by 116
Suplita, R. L., Farthing, J. N., Gutierrez, T., & Hohmann, A. G. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.07.007 · Cited by 115
Scuderi, C., Stecca, C., Valenza, M., Ratano, P., Bronzuoli, M. R., Bartoli, S., Steardo, L., Pompili, E., Fumagalli, L., Campolongo, P., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.376 · Cited by 114
Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels
PETROCELLIS, L. D., & Marzo, V. D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.021 · Cited by 114
Nirodi, C. S., Crews, B. C., Kozak, K. R., Morrow, J. D., & Marnett, L. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303950101 · Cited by 113
The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice
Shafaroodi, H., Samini, M., Moezi, L., Homayoun, H., Sadeghipour, H., Tavakoli, S., Hajrasouliha, A. R., & Dehpour, A. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.011 · Cited by 112
Romero, J., Berrendero, F., Pérez‐Rosado, A., Manzanares, J., Rojo, A., Fernández‐Ruíz, J., de Yébenes, J. G., & Ramos, J. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00618-9 · Cited by 112
Scuderi, C., Valenza, M., Stecca, C., Esposito, G., Carratù, M. R., & Steardo, L. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-49 · Cited by 112
Release of Fatty Acid Amides in a Patient With Hemispheric Stroke
Schäbitz, W.-R., Giuffrida, A., Berger, C., Aschoff, A. A., Schwaninger, M., Schwab, S., & Piomelli, D. (2002) · Stroke · doi:10.1161/01.str.0000023491.63693.18 · Cited by 111
Murillo‐Rodríguez, E., Désarnaud, F., & Prospero-Garcia, O. E. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.028 · Cited by 111
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications
Pertwee, R. G. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113003649 · Cited by 111
Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide
Scuderi, C., Esposito, G., Blasio, A., Valenza, M., Arietti, P., Steardo, L., Carnuccio, R., Filippis, D. D., Petrosino, S., Iuvone, T., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01267.x · Cited by 110
Self-citationExpression of cannabinoid CB 1 receptor mRNA in basal ganglia of normal and parkinsonian human brain
Hurley, M. J., Mash, D. C., & Jenner, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0033-7 · Cited by 109
Citraro, R., Russo, E., Scicchitano, F., van Rijn, C. M., Cosco, D., Avagliano, C., Russo, R., D’Agostino, G., Petrosino, S., Guida, F., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.017 · Cited by 109
Self-citationIncreased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
Izzo, A. A., Aviello, G., Petrosino, S., Orlando, P., Marsicano, G., Lutz, B., Borrelli, F., Capasso, R., Nigam, S., Capasso, F., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0248-4 · Cited by 109
Self-citationLoría, F., Petrosino, S., Mestre, L., Spagnolo, A., Correa, F., Hernangómez, M., Guaza, C., Di Marzo, V., & Docagne, F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06377.x · Cited by 109
Self-citationInhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice
Capasso, R., Izzo, A. A., Fezza, F., Pinto, A., Capasso, F., Mascolo, N., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704339 · Cited by 108
King, A. R., Duranti, A., Tontini, A., Rivara, S., Rosengarth, A., Clapper, J. R., Astarita, G., Geaga, J. A., Luecke, H., Mor, M., et al. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.017 · Cited by 108
Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A. H., Maione, S., & Marzo, V. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031111 · Cited by 108
Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor
Diep, T. A., Madsen, A. N., Holst, B., Kristiansen, M. M., Wellner, N., Hansen, S. H., & Hansen, H. S. (2010) · The FASEB Journal · doi:10.1096/fj.10-166595 · Cited by 108
Valdeolivas, S., Satta, V., Pertwee, R. G., Fernández‐Ruíz, J., & Sagredo, O. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200114w · Cited by 107
CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay
Muccioli, G. G., Labar, G., & Lambert, D. M. (2008) · ChemBioChem · doi:10.1002/cbic.200800428 · Cited by 107
Sun, F., Guo, W., Zheng, D.-H., Zhang, C., Li, S., Liu, S., Yin, Q., Yang, H., & Shu, H. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9878-2 · Cited by 106
Fidaleo, M., Fanelli, F., Cerù, M. P., & Moreno, S. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140303143455 · Cited by 106
Sasso, O., Moreno‐Sanz, G., Martucci, C., Realini, N., Dionisi, M., Mengatto, L., Duranti, A., Tarozzo, G., Tarzia, G., Mor, M., et al. (2012) · Pain · doi:10.1016/j.pain.2012.10.018 · Cited by 106
Balvers, M. G. J., Verhoeckx, K. C. M., & Witkamp, R. F. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.04.010 · Cited by 105
The endocannabinoid system as a target for the treatment of neuronal damage
Fernández‐Ruíz, J., García, C., Sagredo, O., Gómez‐Ruíz, M., & de Lago, E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003709792 · Cited by 105
Endocannabinoids modulate human blood–brain barrier permeability in vitro
Hind, W. H., Tufarelli, C., Neophytou, M., Anderson, S., England, T. J., & O’Sullivan, S. E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13106 · Cited by 103
Sharir, H., Console‐Bram, L., Mundy, C., Popoff, S. N., Kapur, A., & Abood, M. E. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9351-6 · Cited by 101
Lipid Droplets Are Novel Sites of N-Acylethanolamine Inactivation by Fatty Acid Amide Hydrolase-2
Kaczocha, M., Glaser, S. T., Chae, J., Brown, D. A., & Deutsch, D. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058461 · Cited by 101
Imperatore, R., Morello, G., Luongo, L., Taschler, U., Romano, R., Gregorio, D. D., Belardo, C., Maione, S., Marzo, V. D., & Cristino, L. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13267 · Cited by 100
Kargl, J., Balenga, N. A. B., Parzmair, G. P., Brown, A. J., Heinemann, Á., & Waldhoer, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364109 · Cited by 99
Ward, R. J., Pediani, J. D., & Milligan, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.287649 · Cited by 99
Kong, W., Li, H., Tuma, R. F., & Ganea, D. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.11.002 · Cited by 99
Sang, N., Zhang, J., & Chen, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04668.x · Cited by 98
Karanian, D. A., Karim, S. L., Wood, J. T., Williams, J. S., Lin, S., Makriyannis, A., & Bahr, B. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120147 · Cited by 98
Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells
Berdyshev, E. V., Schmid, P. C., Dong, Z., & Schmid, H. H. O. (2000) · Biochemical Journal · doi:10.1042/bj3460369 · Cited by 97
Valdeolivas, S., Pazos, M. R., Bisogno, T., Piscitelli, F., Iannotti, F. A., Allarà, M., Sagredo, O., Marzo, V. D., & Fernández‐Ruíz, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.387 · Cited by 97
Self-citationGonzalez‐Reyes, L. E., Ladas, T. P., Chiang, C., & Durand, D. M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.010 · Cited by 96
Iannotti, F. A., Silvestri, C., Mazzarella, E., Martella, A., Calvigioni, D., Piscitelli, F., Ambrosino, P., Petrosino, S., Czifra, G., Bı́ró, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406728111 · Cited by 96
Self-citationVelasco, G., Carracedo, A., Blázquez, C., Lorente, M., Aguado, T., Haro, A., Sánchez, C., Galve‐Roperh, I., & Guzmán, M. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0002-5 · Cited by 96
TRPV1 in the Central Nervous System: Synaptic Plasticity, Function, and Pharmacological Implications
Edwards, J. G. (2014) · Springer eBooks · doi:10.1007/978-3-0348-0828-6_3 · Cited by 95
Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels
Nomura, D. K., Hudak, C. S. S., Ward, A. M., Burston, J. J., Issa, R. S., Fisher, K. J., Abood, M. E., Wiley, J. L., Lichtman, A. H., & Casida, J. E. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.007 · Cited by 95
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
Martínez‐Pinilla, E., Reyes‐Resina, I., Oñatibia‐Astibia, A., Zamarbide, M., Ricobaraza, A., Navarro, G., Moreno, E., Dopeso‐Reyes, I. G., Sierra, S., Rico, A. J., et al. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.017 · Cited by 95
Navarria, A., Tamburella, A., Iannotti, F. A., Micale, V., Camillieri, G., Gozzo, L., Verde, R., Imperatore, R., Leggio, G. M., Drago, F., et al. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.04.014 · Cited by 95
Self-citationEpigenetic mechanisms and endocannabinoid signalling
D’Addario, C., Francesco, A. D., Pucci, M., Finazzi‐Agrò, A., & Maccarrone, M. (2013) · FEBS Journal · doi:10.1111/febs.12125 · Cited by 95
Mu, J., Zhuang, S.-Y., Kirby, M. T., Hampson, R. E., & Deadwyler, S. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35181-x · Cited by 93
Guggenhuber, S., Monory, K., Lutz, B., & Klugmann, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015707 · Cited by 93
Giuffrida, A., & Piomelli, D. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00046-5 · Cited by 93
Allen, K. L., Waldvogel, H. J., Glass, M., & Faull, R. L. M. (2009) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2009.02.001 · Cited by 92
Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol
Blednov, Y. A., & Harris, R. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.01.007 · Cited by 92
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
Esposito, E., & Cuzzocrea, S. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010010 · Cited by 92
Oleoyl serine, an endogenous N -acyl amide, modulates bone remodeling and mass
Smoum, R., Bar, A., Tan, B., Milman, G., Attar-Namdar, M., Ofek, O., Stuart, J. M., Bajayo, A., Tam, J., Kram, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912479107 · Cited by 91
McFarland, M. J., & Barker, E. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.008 · Cited by 91
Paterniti, I., Cordaro, M., Campolo, M., Siracusa, R., Cornelius, C., Navarra, M., Cuzzocrea, S., & Esposito, E. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140806124322 · Cited by 90
Fernández‐Suárez, D., Celorrio, M., Riezu‐Boj, J. I., Ugarte, A., Pacheco, R., González, H., Oyarzábal, J., Hillard, C. J., Franco, R., & Aymerich, M. S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.021 · Cited by 90
Sang, N., Zhang, J., & Chen, C. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105569 · Cited by 89
Matias, I., Wang, J. W., Moriello, A. S., Nieves, A., Woodward, D. F., & Di Marzo, V. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.08.002 · Cited by 89
de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega‐Gutiérrez, S., Fernández‐Ruíz, J., & Marzo, V. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.011 · Cited by 89
Self-citationAnnuzzi, G., Piscitelli, F., Marino, L. D., Patti, L., Giacco, R., Costabile, G., Bozzetto, L., Riccardi, G., Verde, R., Petrosino, S., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-43 · Cited by 89
Self-citationBanni, S., & Marzo, V. D. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900516 · Cited by 88
Bernal-Chico, A., Canedo, M., Manterola, A., Victoria Sánchez-Gómez, M., Pérez-Samartín, A., Rodríguez-Puertas, R., Matute, C., & Mato, S. (2015) · Glia · doi:10.1002/glia.22742 · Cited by 87
Meschler, J. P., Howlett, A. C., & Madras, B. K. (2001) · Psychopharmacology · doi:10.1007/s002130100728 · Cited by 87
Capasso, R., Orlando, P., Pagano, E., Aveta, T., Buono, L., Borrelli, F., Marzo, V. D., & Izzo, A. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12759 · Cited by 86
Bisogno, T., Martire, A., Petrosino, S., Popoli, P., & Marzo, V. D. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.031 · Cited by 86
Self-citationTsuboi, K., Zhao, L.-Y., Okamoto, Y., Araki, N., Ueno, M., Sakamoto, H., & Ueda, N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.03.005 · Cited by 86
Haghani, M., Shabani, M., Javan, M., Motamedi, F., & Janahmadi, M. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000338494 · Cited by 86
Vilela, L., Medeiros, D. D. C., Rezende, G. H. D. S. E., de Oliveira, A. C. P., Moraes, M. F. D., & Moreira, F. A. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.11.006 · Cited by 86
Verhoeckx, K. C. M., Voortman, T., Balvers, M. G. J., Hendriks, H., Wortelboer, H. M., & Witkamp, R. F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.008 · Cited by 86
Ueda, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00053-9 · Cited by 85
Zhou, Y., Yang, L., Ma, A., Zhang, X., Li, W., Yang, W., Chen, C., & Jin, X. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.008 · Cited by 84
Manna, S. S. S., & Umathe, S. N. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.02.003 · Cited by 84
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
Pisani, V., Moschella, V., Bari, M., Fezza, F., Galati, S., Bernardi, G., Stanzione, P., Pisani, A., & Maccarrone, M. (2010) · Movement Disorders · doi:10.1002/mds.23014 · Cited by 84
The Endocannabinoid System in Huntingtons Disease
Pazos, M. R., Sagredo, O., & Fernández‐Ruíz, J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740108 · Cited by 83
Targeted lipidomics: Discovery of new fatty acyl amides
Tan, B., Bradshaw, H. B., Rimmerman, N., Srinivasan, H., Yu, Y. W., Krey, J. F., Monn, M. F., Chen, J. S.-C., Hu, S. S., Pickens, S. R., et al. (2006) · The AAPS Journal · doi:10.1208/aapsj080354 · Cited by 83
Microglia produce and hydrolyze palmitoylethanolamide
Muccioli, G. G., & Stella, N. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.015 · Cited by 83
Alger, B. E. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.220855 · Cited by 82
Pharmacology of the Capsaicin Receptor, Transient Receptor Potential Vanilloid Type-1 Ion Channel
Nagy, I., Friston, D., Valente, J. D. S., Torres-Pérez, J. V., & Andreou, A. P. (2014) · Springer eBooks · doi:10.1007/978-3-0348-0828-6_2 · Cited by 82
Rahimi, A., Faizi, M., Talebi, F., Noorbakhsh, F., Kahrizi, F., & Naderi, N. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.030 · Cited by 82
TRPV1 Channels Regulate Cortical Excitability in Humans
Mori, F., Ribolsi, M., Kusayanagi, H., Monteleone, F., Mantovani, V., Buttari, F., Marasco, E., Bernardi, G., Maccarrone, M., & Centonze, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2531-11.2012 · Cited by 82
Benito, C., Tolón, R. M., Castillo, A. I., Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Fernández, J., Vázquez, C., Cravatt, B. F., & Romero, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01889.x · Cited by 81
Campora, L., Miragliotta, V., Ricci, E., Cristino, L., Marzo, V. D., Albanese, F., della Valle, M. F., & Abramo, F. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.7.988 · Cited by 81
de Lago, E., Moreno‐Martet, M., Cabranes, A., Ramos, J. A., & Fernández‐Ruíz, J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.030 · Cited by 80
Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
Przybyla, J. A., & Watts, V. J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162701 · Cited by 79
The CB1Cannabinoid Receptor in the Brain
Howlett, A. C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0215 · Cited by 79
Dowie, M. J., Howard, M. L., Nicholson, L. F. B., Faull, R. L. M., Hannan, A. J., & Glass, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.056 · Cited by 78
Altamura, C., Ventriglia, M., Martini, M. G., Montesano, D., Errante, Y., Piscitelli, F., Scrascia, F., Quattrocchi, C. C., Palazzo, P., Seccia, S., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142349 · Cited by 77
Wen, J., Ribeiro, R., Tanaka, M., & Zhang, Y. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.010 · Cited by 77
Feliú, A., Moreno‐Martet, M., Mecha, M., Carrillo-Salinas, F. J., de Lago, E., Fernández‐Ruíz, J., & Guaza, C. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13159 · Cited by 77
Bisogno, T., Ortar, G., Petrosino, S., Morera, E., Palazzo, E., Nalli, M., Maione, S., & Marzo, V. D. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.10.007 · Cited by 77
Self-citationSelective Antiepileptic Effects ofN‐Palmitoylethanolamide, a Putative Endocannabinoid
Sheerin, A. H., Zhang, X., Saucier, D. M., & Corcoran, M. E. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.16604.x · Cited by 76
Anti-inflammatory activity on compounds obtained from egg yolk, peanut oil, and soybean lecithin.
Ganley, O. H., Graessle, O. E., & Robinson, H. J. (1958) · PubMed · Cited by 74
Endocannabinoids Anandamide and 2-Arachidonoylglycerol Are Substrates for Human CYP2J2 Epoxygenase
McDougle, D. R., Kambalyal, A., Meling, D. D., & Das, A. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216598 · Cited by 71
Tsuboi, K., HILLIGSMANN, C., Vandevoorde, S., Lambert, D. M., & Ueda, N. (2004) · Biochemical Journal · doi:10.1042/bj20031695 · Cited by 70
Lastres‐Becker, I., Bizat, N., Boyer, F., Hantraye, P., Brouillet, E., & Fernández‐Ruíz, J. (2003) · Neuroreport · doi:10.1097/00001756-200305060-00007 · Cited by 69
D’Argenio, G., Petrosino, S., Gianfrani, C., Valenti, M., Scaglione, G., Grandone, I., Nigam, S., Sorrentini, I., Mazzarella, G., & Marzo, V. D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0192-3 · Cited by 67
Self-citationSchreiber, D., Harlfinger, S., Nolden, B. M., Gerth, C. W., Jaehde, U., Schömig, E., Klosterkötter, J., Giuffrida, A., Astarita, G., Piomelli, D., et al. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.11.027 · Cited by 66
COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity
Yang, H., Zhang, J., Andreasson, K. I., & Chen, C. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.12.019 · Cited by 66
Okine, B. N., Norris, L. M., Woodhams, S. G., Burston, J. J., Patel, A., Alexander, S. P. H., Barrett, D. A., Kendall, D. A., Bennett, A. J., & Chapman, V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02028.x · Cited by 65
Pisani, A., Bonsi, P., Picconi, B., Tolu, M., Giacomini, P., & Scarnati, E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00153-6 · Cited by 65
Sánchez, A., González-Pérez, P., Galve‐Roperh, I., & García‐Merino, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.018 · Cited by 65
Nabilone increases choreatic movements in Huntington's disease
Müller‐Vahl, K., Schneider, U., & Emrich, H. M. (1999) · Movement Disorders · doi:10.1002/1531-8257(199911)14:6<1038::aid-mds1024>3.0.co;2-7 · Cited by 65
Galán-Rodríguez, B., Suárez, J., González-Aparicio, R., Bermúdez‐Silva, F. J., Maldonado, R. J., Robledo, P., de Fonseca, F. R., & Fernández‐Espejo, E. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.11.006 · Cited by 64
Coleman, R., & Haynes, E. B. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42457-4 · Cited by 63
Quintão, N. L. M., Medeiros, R., Santos, A. R. S., Campos, M. M., & Calixto, J. Β. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000184182.03203.61 · Cited by 63
Ternianov, A., Pérez‐Ortiz, J. M., Solesio, M. E., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Navarrete, F., Leiva, C., Galindo, M. F., & Manzanares, J. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.012 · Cited by 63
Filippis, D. D., D’Amico, A., Cipriano, M., Petrosino, S., Orlando, P., Marzo, V. D., & Iuvone, T. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.11.005 · Cited by 63
Self-citationRegulation of TRP channels: a voltage–lipid connection
Nilius, B., Mahieu, F., Karashima, Y., & Voets, T. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350105 · Cited by 63
Łuszczki, J. J., Czuczwar, P., Cioczek‐Czuczwar, A., & Czuczwar, S. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.037 · Cited by 62
Kozan, R., Ayyıldız, M., & Ağar, E. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02098.x · Cited by 62
Resolution of inflammation by N‐arachidonoylglycine
BURSTEIN, S. H., McQuain, C., Ross, A. H., Salmonsen, R. A., & Zurier, R. E. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23245 · Cited by 62
Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL
Fan, A., Wu, X., Wu, H., Li, L., Huang, R., Zhu, Y., Qiu, Y., Fu, J., Ren, J., & Zhu, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085337 · Cited by 61
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Melis, M., & Pistis, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793612 · Cited by 61
Endocannabinoid metabolism by cytochrome P450 monooxygenases
Zelasko, S. E., Arnold, W. R., & Das, A. (2014) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2014.11.002 · Cited by 61
TRPV1 and Endocannabinoids: Emerging Molecular Signals that Modulate Mammalian Vision
Ryskamp, D., Redmon, S., Jo, A., & Križaj, D. (2014) · Cells · doi:10.3390/cells3030914 · Cited by 60
Battista, N., Bari, M., Tarditi, A., Mariotti, C., Bachoud‐Lévi, A., Zuccato, C., Finazzi‐Agrò, A., Genitrini, S., Peschanski, M., Donato, S. D., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.012 · Cited by 60
Esposito, E., & Cuzzocrea, S. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955713804805184 · Cited by 60
Ahmad, A., Genovese, T., Impellizzeri, D., Crupi, R., Velardi, E., Marino, A., Esposito, E., & Cuzzocrea, S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.08.006 · Cited by 58
Nabilone Could Treat Chorea and Irritability in Huntington's Disease
Curtis, A., & Rickards, H. E. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.4.553 · Cited by 58
N -Arachidonoyl- l -Serine is Neuroprotective after Traumatic Brain Injury by Reducing Apoptosis
Cohen‐Yeshurun, A., Trembovler, V., Alexandrovich, A. G., Ryberg, E., Greasley, P. J., Mechoulam, R., Shohami, E., & Leker, R. R. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.53 · Cited by 55
Naidoo, V., Nikas, S. P., Karanian, D. A., Hwang, J., Zhao, J., Wood, J. T., Alapafuja, S. O., Vadivel, S. K., Butler, D., Makriyannis, A., et al. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9472-4 · Cited by 55
Anandamide-derived Prostamide F2α Negatively Regulates Adipogenesis
Silvestri, C., Martella, A., Poloso, N. J., Piscitelli, F., Capasso, R., Izzo, A. A., Woodward, D. F., & Marzo, V. D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.489906 · Cited by 54
The Endocannabinoid System and Multiple Sclerosis
Baker, D., & Pryce, G. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740036 · Cited by 54
Solorzano, C., Antonietti, F., Duranti, A., Tontini, A., Rivara, S., Lodola, A., Vacondio, F., Tarzia, G., Piomelli, D., & Mor, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100582w · Cited by 54
de Novellis, V., Luongo, L., Guida, F., Cristino, L., Palazzo, E., Russo, R., Marabese, I., D’Agostino, G., Calignano, A., Rossi, F., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.034 · Cited by 54
Modulation of Pilocarpine-Induced Seizures by Cannabinoid Receptor 1
Kow, R. L., Jiang, K., Naydenov, A. V., Le, J. H., Stella, N., & Nathanson, N. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095922 · Cited by 53
Interferon-γ Safeguards Blood-Brain Barrier during Experimental Autoimmune Encephalomyelitis
Chen, N., Wang, C., Zhang, J., Qu, L.-W., Liu, X., Lu, Y., Yang, W. C., Deng, J., Lorenz, D., Gao, P., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.019 · Cited by 53
Production and Actions of the Anandamide Metabolite Prostamide E2 in the Renal Medulla
Ritter, J. K., Li, C., Xia, M., Poklis, J. L., Lichtman, A. H., Abdullah, R. A., Dewey, W. L., & Li, P. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.196451 · Cited by 53
Zhao, L.-Y., Tsuboi, K., Okamoto, Y., Nagahata, S., & Ueda, N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.10.002 · Cited by 52
Li, Y., Yang, L., Chen, L., Zhu, C., Huang, R., Zheng, X., Qiu, Y., & Fu, J. X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043023 · Cited by 50
Analysis of the “endocannabinoidome” in peripheral tissues of obese Zucker rats
Iannotti, F. A., Piscitelli, F., Martella, A., Mazzarella, E., Allarà, M., Palmieri, V., Parrella, C., Capasso, R., & Marzo, V. D. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.06.002 · Cited by 50
Self-citationEndocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.
Matias, I., & Marzo, V. D. (2006) · PubMed · Cited by 49
Possible Anandamide and Palmitoylethanolamide involvement in human stroke
Naccarato, M., Pizzuti, D., Petrosino, S., Simonetto, M., Ferigo, L., Grandi, F., Pizzolato, G., & Marzo, V. D. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-47 · Cited by 49
Self-citationThe putative cannabinoid receptor GPR55 promotes cancer cell proliferation
Hu, G., Ren, G., & Shi, Y. (2010) · Oncogene · doi:10.1038/onc.2010.502 · Cited by 49
Saturnino, C., Petrosino, S., Ligresti, A., Palladino, C., Martino, G., Bisogno, T., & Marzo, V. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.134 · Cited by 49
Self-citationShirazi, M., Izadi, M., Amin, M., Rezvani, M. E., Roohbakhsh, A., & Shamsizadeh, A. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1689-5 · Cited by 48
Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G. M., Drago, F., & Marzo, V. D. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.015 · Cited by 48
Self-citationDuranti, A., Tontini, A., Antonietti, F., Vacondio, F., Fioni, A., Silva, C., Lodola, A., Rivara, S., Solorzano, C., Piomelli, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300349j · Cited by 48
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB2 Receptors
Aymerich, M. S., Rojo-Bustamante, E., Molina, C., Celorrio, M., Sánchez-Arias, J. A., & Franco, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9213-3 · Cited by 47
The Endocannabinoid System: A Putative Role in Neurodegenerative Diseases
Iorio, G. D., Lupi, M., Sarchione, F., Matarazzo, I., Santacroce, R., Petruccelli, F., Martinotti, G., & Giannantonio, M. D. (2013) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.9222 · Cited by 47
Ponzano, S., Bertozzi, F., Mengatto, L., Dionisi, M., Armirotti, A., Romeo, E., Berteotti, A., Fiorelli, C., Tarozzo, G., Reggiani, A. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400739u · Cited by 47
Endocannabinoid signaling and its regulation by nutrients
Bisogno, T., & Maccarrone, M. (2014) · BioFactors · doi:10.1002/biof.1167 · Cited by 46
Abramo, F., Campora, L., Albanese, F., della Valle, M. F., Cristino, L., Petrosino, S., Marzo, V. D., & Miragliotta, V. (2014) · BMC Veterinary Research · doi:10.1186/1746-6148-10-21 · Cited by 46
Self-citationCohen‐Yeshurun, A., Willner, D., Trembovler, V., Alexandrovich, A. G., Mechoulam, R., Shohami, E., & Leker, R. R. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.75 · Cited by 45
Vandevoorde, S., Tsuboi, K., Ueda, N., Jonsson, K., Fowler, C. J., & Lambert, D. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0340795 · Cited by 44
Ambrosino, P., Soldovieri, M. V., Maria, M. D., Russo, C., & Taglialatela, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.015 · Cited by 44
Dempsey, D. R., Jeffries, K. A., Anderson, R. L., Carpenter, A., Opsina, S. R., & Merkler, D. J. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.12.027 · Cited by 43
Cannabinoids and intestinal motility: welcome to CB2 receptors
Izzo, A. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705890 · Cited by 43
Kingsley, P. J., Rouzer, C. A., Saleh, S., & Marnett, L. J. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.05.005 · Cited by 43
Banoua, F. E., Caraballo, I., Flores, J. A., Galán-Rodríguez, B., & Fernández‐Espejo, E. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.002 · Cited by 42
Iwaoka, E., Wang, S., Matsuyoshi, N., Kogure, Y., Aoki, S., Yamamoto, S., Noguchi, K., & Dai, Y. (2015) · Journal of Natural Medicines · doi:10.1007/s11418-015-0929-1 · Cited by 41
Petrosino, S., Ahmad, A., Marcolongo, G., Esposito, E., Allarà, M., Verde, R., Cuzzocrea, S., & Marzo, V. D. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.10.008 · Cited by 41
Self-citationZogopoulos, P., Vasileiou, I., Patsouris, E., & Theocharis, S. E. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2828 · Cited by 39
Arévalo‐Martín, Á., Molina‐Holgado, E., & Guaza, C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.012 · Cited by 39
Pryce, G., Cabranes, A., Fernández‐Ruíz, J., Bisogno, T., Marzo, V. D., Long, J. Z., Cravatt, B., Giovannoni, G., & Baker, D. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513485982 · Cited by 39
Naderi, N., Ahmad-Molaei, L., Ahari, F. A., & Motamedi, F. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0479-1 · Cited by 39
The endocannabinoidome : the world of endocannabinoids and related mediators
Marzo, V. D., & Wang, J. Y. (2015) · Cited by 38
Cerri, S., Levandis, G., Ambrosi, G., Montepeloso, E., Antoninetti, G., Franco, R., Lanciego, J. L., Baqi, Y., Müller, C. E., Pinna, A., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000064 · Cited by 38
García, M. D. C., Adler‐Graschinsky, E., & Celuch, S. M. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.021 · Cited by 38
Oxidation of Endogenous N-Arachidonoylserotonin by Human Cytochrome P450 2U1
Šiller, M., Goyal, S., Yoshimoto, F. K., Xiao, Y., Wei, S., & Guengerich, F. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550004 · Cited by 37
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors
Aghaei, I., Rostampour, M., Shabani, M., Naderi, N., Motamedi, F., Babaei, P., & Khakpour-Taleghani, B. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.08.010 · Cited by 37
TRP Channels and Psychiatric Disorders
Chahl, L. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_51 · Cited by 36
Erratum to: Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels
van der Stelt, M., Trevisani, M. M., Vellani, V., PETROCELLIS, L. D., Moriello, A. S., Campi, B., McNaughton, P., Geppetti, P., & Marzo, V. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600839 · Cited by 34
Ribeiro, R., Yu, F., Wen, J., Vana, A. C., & Zhang, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.005 · Cited by 31
Fiasella, A., Nuzzi, A., Summa, M., Armirotti, A., Tarozzo, G., Tarzia, G., Mor, M., Bertozzi, F., Bandiera, T., & Piomelli, D. (2014) · ChemMedChem · doi:10.1002/cmdc.201300546 · Cited by 28
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
Notcutt, W. G. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0383-5 · Cited by 27
Talwar, R., & Potluri, V. K. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711796235005 · Cited by 27
Ducassou, L., Jonasson, G., Dhers, L., Pietrancosta, N., Ramassamy, B., Li, Y., Loriot, M., Beaune, P. H., Bertho, G., Lombard, M., et al. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.03.014 · Cited by 26
Effects of single swim stress on changes in TRPV1-mediated plasticity in the amygdala
Kulisch, C., & Albrecht, D. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.003 · Cited by 24
Haghani, M., Janahmadi, M., & Shabani, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.044 · Cited by 24
Liu, Z., Song, L., Yang, X., Ma, Y., & Wu, N. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s60944 · Cited by 22
McFarland, M. J., Bardell, T. K., Yates, M. L., Placzek, E. A., & Barker, E. L. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.044834 · Cited by 22
Enhanced microglial activity in FAAH−/− animals
Ativie, F., Albayram, Ö., Bach, K., Pradier, B., Zimmer, A., & Bilkei‐Gorzó, A. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.12.016 · Cited by 20
Marchalant, Y., Baranger, K., Wenk, G. L., Khrestchatisky, M., & Rivera, S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-10 · Cited by 20
Cannabinoids, multiple sclerosis and neuroprotection
de Lago, E., Gómez‐Ruíz, M., Moreno‐Martet, M., & Fernández‐Ruíz, J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.42 · Cited by 20
Witkowski, G., Rola, R., & Szulczyk, P. J. (2012) · PubMed · Cited by 18
Lyman, W. D., Abrams, G. A., & Raine, C. S. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90137-9 · Cited by 15
Cordaro, M., Impellizzeri, D., Bruschetta, G., Siracusa, R., Crupi, R., Paola, R. D., Esposito, E., & Cuzzocrea, S. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.10.006 · Cited by 12
Cited by
Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications
Carta, G., Murru, E., Banni, S., & Manca, C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00902 · Cited by 809
Petrosino, S., & Di Marzo, V. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13580 · Cited by 328
Self-citationTargeting the endocannabinoid system: future therapeutic strategies
Aizpurua-Olaizola, O., Elezgarai, I., Rico-Barrio, I., Zarandona, I., Etxebarria, N., & Usobiaga, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.08.005 · Cited by 209
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Maccarrone, M., Di Marzo, V., Gertsch, J., Grether, U., Howlett, A. C., Hua, T., Makriyannis, A., Piomelli, D., Ueda, N., & van der Stelt, M. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000600 · Cited by 183
Lipids in Psychiatric Disorders and Preventive Medicine
Schneider, M., Levant, B., Reichel, M., Gulbins, E., Kornhuber, J., & Müller, C. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.002 · Cited by 175
Metadata
- Authors
- Iannotti, F. A., Di Marzo, V., & Petrosino, S.
- Venue
- Progress in Lipid Research
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 62
- Pages
- 107-128
- ISSN
- 0163-7827 (ISSN-L)
- OpenAlex
- W2295932321
- Cited by
- 357
- References
- 395
- FWCI
- 27.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.